Neuphoria Therapeutics (NEUP) Net Shares Issued and Repurchased (2023 - 2025)

Neuphoria Therapeutics (NEUP) has reported Net Shares Issued and Repurchased for 3 consecutive years, with $34559.0 the latest figure, recorded in Q4 2025.

• On a quarterly basis, Net Shares Issued and Repurchased changed N/A year-over-year to $34559.0 in Q4 2025; TTM through Dec 2025 was $34559.0, a N/A change from a year earlier, with the FY2025 full-year figure at $40500.0, down 99.31% from the prior year.
• Net Shares Issued and Repurchased was $34559.0 for Q4 2025 at Neuphoria Therapeutics, down from $51839.0 in the prior quarter.
• Over five years, Net Shares Issued and Repurchased peaked at $28.8 million in Q2 2023 and troughed at $34559.0 in Q4 2025.
• A 3-year average of $7.0 million and a median of $51839.0 in 2025 frame the typical range for Net Shares Issued and Repurchased.
• Across the five-year window, Net Shares Issued and Repurchased plunged 79.73% in 2024 and plunged 99.31% in 2025, its largest moves.
• Over 3 years, Net Shares Issued and Repurchased stood at $28.8 million in 2023, then sank by 79.73% to $5.8 million in 2024, then tumbled by 99.41% to $34559.0 in 2025.
• The last three Net Shares Issued and Repurchased figures came in at $34559.0 (Q4 2025), $51839.0 (Q3 2025), and $40500.0 (Q2 2025), per Business Quant data.